MarketScreener Editorial Features Zealand Pharma A/S
Equities
ZEAL
DK0060257814
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
764.00 DKK | +0.79% | +2.61% | +105.25% |
MarketScreener Editorial Features
Zealand Pharma, a new competitor for Novo Nordisk? | January 24, 2024 at 10:14 am |
- Stock Market
- Equities
- ZEAL Stock
- News Zealand Pharma A/S
- MarketScreener Editorial Features
MarketScreener is also available in this country: United States.
Switch edition